BlackRock Group’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$1.61M Buy
32,877
+9,608
+41% +$470K ﹤0.01% 1893
2016
Q3
$1.11M Buy
23,269
+1,963
+9% +$94K ﹤0.01% 1960
2016
Q2
$1.14M Buy
21,306
+977
+5% +$52.4K ﹤0.01% 1895
2016
Q1
$909K Buy
20,329
+2,881
+17% +$129K ﹤0.01% 1971
2015
Q4
$666K Sell
17,448
-2,354
-12% -$89.9K ﹤0.01% 2078
2015
Q3
$630K Buy
19,802
+1,209
+7% +$38.5K ﹤0.01% 2094
2015
Q2
$614K Buy
18,593
+2,069
+13% +$68.3K ﹤0.01% 2175
2015
Q1
$680K Sell
16,524
-274
-2% -$11.3K ﹤0.01% 2056
2014
Q4
$685K Sell
16,798
-12,443
-43% -$507K ﹤0.01% 2094
2014
Q3
$1.07M Sell
29,241
-3,996
-12% -$146K ﹤0.01% 1723
2014
Q2
$1.54M Buy
33,237
+25,375
+323% +$1.18M ﹤0.01% 1576
2014
Q1
$323K Sell
7,862
-1,533
-16% -$63K ﹤0.01% 2328
2013
Q4
$359K Buy
9,395
+3,089
+49% +$118K ﹤0.01% 2280
2013
Q3
$151K Buy
+6,306
New +$151K ﹤0.01% 2525